Incentive Spirometry in Routine Management of COPD Patients

Menoufia University

Status: Completed

Conditions: COPD

Treatments: Device: incentive spirometry

Study type: Interventional

Funder types: Other

Identifiers

NCT05679609

6/2022CHES4-1

Details and patient eligibility

About

The incentive spirometer is a device that encourages patients, with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. However, its efficacy in patients with COPD has been little documented especially in diaphragmatic function. This study tried to assess the role of incentive spirometry on Spirometric functions, Sonographic diaphragmatic function, and the scale of dyspnea in COPD patients with exacerbation and with follow-up of these parameters after 2 months.

Full description

Forty COPD patients were admitted with an acute exacerbation and the patients were divided randomly into 2 equal groups: the first used the incentive spirometer together with medical treatment (according to GOLD guidelines) for 2 months and the second received only medical treatment for 2 months. All participants, on admission, underwent assessment of mMRC dyspnea scale, spirometry, arterial blood gases, and diaphragmatic ultrasound. Then, a follow-up of the participants was done after 2 months with the same parameters and a comparison between both groups was done.

Enrollment: 40 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed cases of COPD according to the criteria GOLD
• age more than 40 years

Exclusion criteria

• bad acoustic window by ultrasound
• other chronic respiratory diseases
• lung malignancy
• recent major surgery
• inability to complete or perform the study
• patient refusal

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

group 1

Experimental group

Description:

participants would use incentive spirometry for 2 months together with ordinary medical treatment

Treatment:

Device: incentive spirometry

group 2

No Intervention group

Description:

participants would receive only ordinary medical treatment for 2 months